FEATURED COMPANIES
- Abbott Laboratories
- Artsana S.p.A
- B. Braun Melsungen AG
- BD
- Eli Lilly and Company
- Insulet Corporation
Diabetes is rising at an alarming rate in the United States. Diabetes referred to as diabetes mellitus, is a group of metabolic diseases in which a person suffers from high blood glucose. If diabetes is not appropriately monitored, then it can be fatal and cause serious health complications such as kidney diseases, heart diseases, amputation, stroke and blindness. Between the year 2000 and 2019, the number of people living with diabetes tripled and the number of new cases annually doubled in the United States. The United States represents the third-largest diabetes patient pool owing to the increasing geriatric population and rising obesity levels in 2018. The United States Diabetes Market is expected to reach USD 26.28 Billion by the year 2025.
The use of continuous glucose monitoring systems and continuous subcutaneous insulin infusion has gained full acceptance in diabetes care. These devices have been demonstrated to be clinically valuable, reducing risks of hypoglycemia and improving glycemic control in ambulatory patients with type 1 diabetes & type 2 diabetes. Because of this tremendous improvement in the number of patients, especially those requiring insulin therapy, the cost of healthcare-related to diabetes and its complications is ever increasing. The market of Insulin Pen, Insulin Pump, Continuous Glucose Monitoring (CGM) Device and Self Monitoring Blood Glucose Device are growing due to the rise in numbers of diabetic patients in the United States.
The increasing diabetes prevalence has led the U.S. government to raise awareness and prevention programs about its symptoms and encourage healthier lifestyle behaviour amongst citizens. In 2019, Abbott Laboratories planned to ramp up manufacturing capacity for its lower-cost continuous glucose monitor (CGM) device in the next few years, aiming to reach millions of more patients worldwide, According to Reuters, in March 2018, Sanofi-aventis U.S. LLC received approval from the U.S. Food and Drug Administration for Toujeo Max SoloStar.
This report provides a complete analysis of United States Insulin Delivery Devices Market.
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)
2. Self Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump
United States Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM)
1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
2. SMBG
1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market
1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Reimbursement Policies
4. Insulin Pump Market
1. Insulin Pump Market
2. USA (By States) - Diabetes Supplies
3. Reimbursement Policies by State-Sponsored Health Program
All the 11 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Recent Developments
- Financial Insight
Company Analysis
1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Artsana S.p.A
4. BD
5. Novo Nordisk A/S
6. Owen Mumford Ltd
7. Ypsomed AG
8. Medtronic
9. Insulet Corporation
10. LifeScan Inc.
11. Abbott Laboratories
Key Benefits of the Report
- This report provides current market estimates and forecasts for the United States Diabetic Market.
- Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
- United States Diabetic Market - Growth Drivers and Challenges.
- Key sustainability strategies adopted by market players.
FEATURED COMPANIES
- Abbott Laboratories
- Artsana S.p.A
- B. Braun Melsungen AG
- BD
- Eli Lilly and Company
- Insulet Corporation
1. Introduction2. Research & Methodology3. Executive Summary
- B. Braun Melsungen AG
- Eli Lilly and Company
- Artsana S.p.A
- BD
- Novo Nordisk A/S
- Owen Mumford Ltd
- Ypsomed AG
- Medtronic
- Insulet Corporation
- LifeScan Inc.
- Abbott Laboratories
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
